Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab

Clinical Kidney Journal

Volumn 9, Issue 4, 2016, Pages 576-579

  Jin, Anna ^a,b   Boroujerdi Rad, Laleh ^a,b   Shah, Gaurang ^a,b   Chen, Joline L T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Long Beach Veteran Administration Health Care System   (United States)

Author keywords

Complement; HIV; Intensive care; Plasma exchange; Thrombotic microangiopathy

Indexed keywords

CD4 ANTIGEN; CREATININE; ECULIZUMAB; HEMOGLOBIN; LACTATE DEHYDROGENASE; POTASSIUM; SHIGA TOXIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ABDOMINAL PAIN; ADULT; ANTICONVULSANT THERAPY; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CD4 LYMPHOCYTE COUNT; CONFUSION; CREATININE BLOOD LEVEL; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; HEMODIALYSIS; HEMOLYSIS; HEMOLYTIC ANEMIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTUBATION; KIDNEY FUNCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LETHARGY; LIVER FUNCTION; MALE; MIDDLE AGED; PLASMAPHERESIS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEIZURE; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TONIC CLONIC SEIZURE; URINALYSIS; URINE SEDIMENT; VIRUS LOAD;

EID: 84992088843     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfw035     Document Type: Article

References (20)

1. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600
2. Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 2001; 60: 831-846
3. George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Eng J Med 2014; 371: 654-666
4. Loirat C, Fakhouri F, Ariceta G et al. for HUS International. An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol 2016; 31: 15-39
5. Nester CM, Barbour T, de Cordoba SR et al. Atypical aHUS: state of the art. Mol Immunol 2015; 67: 31-42
6. Verhave JC, Wetzels JFM, van de Kar NCAJ. Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab. Nephrol Dial Transplant 2014; 29: iv131-iv141
7. Zipfel PF, Edey M, Heinen S et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet 2007; 3: e41
8. Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 2012; 8: 622-633
9. Loirat C, Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 2011; 6: 60
10. Kaplan BS, Ruebner RL, Spinale JM et al. Current treatment of atypical hemolytic uremic syndrome. Intractable Rare Dis Res 2014; 3: 34-45
11. Sta?hl A, Vaziri-Sani F, Heinen S et al. Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation. Blood 2008; 111: 5307-5315
12. Levy GG, Nichols WC, Lian EC et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-494
13. Froehlich-Zahnd R, George JN, Vesely SK et al. Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica 2012; 97: 297-303
14. Boccia RV, Gelmann EP, Baker CC et al. A hemolytic-uremic syndrome with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 716-717
15. Benjamin M, Terrell DR, Vesely SK et al. Frequency and Significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis 2009; 48: 1129-1137
16. Brecher ME, Hay SN, Park YA. Is it HIV TTP or HIV associated thrombotic microangiopathy? J Clin Apher 2008; 23: 186-190
17. Gervasoni C, Ridolofo AL, Vaccarezza M et al. Thromobotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy. Clin Infect Dis 2002; 35: 1534-1540
18. Gunther K, Garizio D, Nesara P. ADAMTS13 activity and the presence of acquired inhibitors in human immunodeficiency virus-related thrombotic thrombocytopenic purpura. Transfusion 2007; 47: 1710-1716
19. Keating G. Eculizumab: a review of its use in atypical haemolytic uraemic syndrome. Drugs 2013; 73: 2053-2066
20. Nester C. Managing atypical hemolytic syndrome: chapter 2. Kidney Int 2015; 87: 882-884